Zachary Roberts - 03 Jan 2023 Form 3 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
EVP of R&D
Signature
/s/Veer Bhavnagri, Attorney-in-Fact
Issuer symbol
ALLO
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
3
Filing time
09 Jan 2023, 16:19:05 UTC
Previous filing
07 Mar 2022
Next filing
24 Jan 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.